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*Initial surgery performed in outside institution.
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Objectives: The combination of D-dimer and Wells
score can exclude, but not confirm, the diagnosis of sus-
pected deep venous thrombosis (DVT). Since thrombosis
and inflammation are interrelated, this study sought to
determine if a combination of inflammatory biomarkers
and clinical scores could establish the diagnosis.
Methods: 152 patients presenting with suspected
DVT, 44 positive and 108 negative by duplex scan, and 30
healthy controls were prospectively evaluated for soluble
P-selectin (sPsel), D-dimer, C-reactive protein (CRP), mi-
croparticles (MP) and Wells score.
Results: Biomarkers and characteristics that discrimi-
nated DVT positives from negatives were sPsel (94.1 vs
53.1 ng/mL, p  0.01), D-dimer (5.8 vs 2.1, p  0.01),
CRP (1.91 vs 0.83 g/mL, p 0.05) and Wells score (3.3
vs 2.0, p  0.01). MP were not found to be significant in
the study. Results, using logistic regression are shown on
the table.
Conclusions: sPselWells can establish the diagnosis
of DVT (115 ng/mL  2), with specificity  93.8%and PPV  100%, and can exclude the diagnosis (35
ng/mL2) with sensitivity 95.8% and NPV 100%.
Based on our data, 38% (58/152) could potentially be
diagnosed with DVT without the need of imaging exams.
Logistic regression results
Variables ROC
p-value
(regression) Sensitivity Specificity PPV NPV
D-dimer (400 ng/
mL)
0.59 0.01 91.7% 35% 31.7% 95.6%
Wells score (2) 0.63 0.01 27.3% 85.2% 34% 79%
sPsel (35 ng/mL) 0.77 0.01 93.3% 14.8% 31.5% 85.7%
sPsel (115 ng/mL) 0.66 0.01 33% 98.1% 93.3% 78.1%
sPsel Wells
(35 ng/mL  2)
0.82 0.01 95.8% 48.8% 30% 100%
sPsel Wells
(115 ng/mL  2)
0.82 0.01 20.8% 98.8% 100% 78%
Of 152 patients, 44 negatives presented sPsel35 ng/mL andWells2 and
14 positives had sPsel115 ng/mL and Wells2.
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Objectives: Recanalization of the greater saphenous
vein (GSV) has been reported as the predominant cause of
treatment failure following endovenous ablation therapy
(EVT) for superficial venous insufficiency. With an increas-
ingly larger clinical experience and a longer follow-up in-
terval after EVT, we aim to report another cause of treat-
ment failure that we have observed.
Methods: Between 2006 and 2010, all patients under-
going EVT for superficial venous insufficiency in a single
ambulatory office were retrospectively reviewed. Patients
who had reintervention on the same venous territory were
identified. All EVT were performed using a 600-m diam-
eter laser fiber and 810-nm diode laser. Statistical analysis
was conducted with SPSS software.
Results: Results: Of the 1271 EVT in our database, 16
patients with treatment failures in 17 limbs (CEAP 2:
52.9%, CEAP 3: 17.6%, CEAP 4: 11.8%, CEAP 5: 11.8%)
were identified. Mean age was 52.9 14.6 and 58.8% were
male. Almost all of the procedures involved the GSV (16/
17) except one small saphenous vein (SSV). Treated lesions
had variable lengths (mean 27.8  17.8cm). All patients
had at least one symptom and the mean time to recurrence
was 16.8 months (range 2 to 34 months). Causes of recur-
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venous tributary (52.9%), recanalization (17.6 %), and ve-
nous perforators (29.4%).
Conclusions: Of the three primary causes of recurrences
after EVT that we observed, reflux from a venous tributary in
close proximity of the SFJ is a major cause of failure. While
under-reported in the literature, the frequency observed sug-
gests that this reason for recurrence will likely increase asmore
EVT are being performed and the duration of follow-up
increases. As venous tributaries are frequently present in closeproximity to the sapheno-femoral junction (SFJ), the current
recommendation of termination of EVT at 2 cm from the SFJ
may contribute to this cause of recurrence and warrants fur-
ther evaluation.
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